Importantly, these data also suggest that inhibition of mTORC1 and S6K1 in the liver is critically important for delaying mitochondrial disease in the brain, perhaps through a change in systemic metabolism that attenuates neuroinflammation and neurodegeneration. Here, RPS6KB1 is linked to mitochondrial disease.